Jubilant Pharmova Outperforms Sector with Strong Short-Term and Long-Term Gains

Jubilant Pharmova has shown significant activity today, gaining 5.32% on April 3, 2025. This midcap pharmaceutical company has outperformed its sector, which rose by 4.06%, by 1.55%. Over the past five days, Jubilant Pharmova has demonstrated a strong upward trend, accumulating a total return of 11.67%. The stock reached an intraday high of Rs 964.55, reflecting a 6% increase during the trading session.
In terms of moving averages, Jubilant Pharmova's stock is currently above its 5-day, 20-day, and 50-day moving averages, although it remains below the 100-day and 200-day moving averages. This performance comes amid a broader market context where the Sensex, after a gap down opening, has shown some recovery, currently trading at 76,233.78, down 0.5%.

Looking at longer-term performance, Jubilant Pharmova has delivered impressive returns over the past year, with a 66.34% increase, significantly outpacing the Sensex's 3.11% gain. Over three, five, and ten years, the stock has also shown remarkable growth, with returns of 134.74%, 258.80%, and 514.54%, respectively.